金吾财讯 | Zimmer Biomet(ZBH)盘前股价上扬，暂升2.14%，报93.1美元。公司第二季度调整后每股利润为2.07美元，高于预期的每股1.98美元。第二季度营收为20.8亿美元，也高于预期的20.5亿美元。公司运动医学和创伤护理产品部门的销售额增长17.3%，达到5.51亿美元，而分析师预计为5.34亿美元。业绩指引方面，公司预计 2025 年收入增长率将达到6.7%至7.7%，而之前预测为5.7%至8.2%。
金吾财讯 | Zimmer Biomet(ZBH)盘前股价上扬，暂升2.14%，报93.1美元。公司第二季度调整后每股利润为2.07美元，高于预期的每股1.98美元。第二季度营收为20.8亿美元，也高于预期的20.5亿美元。公司运动医学和创伤护理产品部门的销售额增长17.3%，达到5.51亿美元，而分析师预计为5.34亿美元。业绩指引方面，公司预计 2025 年收入增长率将达到6.7%至7.7%，而之前预测为5.7%至8.2%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.